EYOTO™ has the technological pipeline, expertise, and unparalleled background IP to complement the increasing demand for both mobile and remote tele-optometry. .
Starting as a developer of cutting-edge white label technologies for other eye care companies, we then moved on to the development and launch of our ground-breaking eMap technology, the world’s first edge to edge, fully digitised, remotely accessible lens analysis system.
The first product in our tele-optometry platform, launching late 2020, will allow an ECP to conduct an eye examination from a remote location – a different room, city, or continent. It eliminates the need for an ECP to be physically present with the patient. This will be followed by a complementary pipeline of remote and mobile technology products.
A significant proportion of the growing optical market can no longer be supplied by traditional care methods due to cost, and in many geographical areas, lack of qualified specialists. Estimates put it that approximately 2.5bn people do not have access to eyecare – 1/3 of the planet’s population.
Patients continue to seek ever more convenient and affordable eyecare. A key component of this convenience is getting care at the times and locations they want.
There is a limit to how many patients an individual Eye Care Practitioner (ECP) can see and a limit to the geographies that they can physically cover in person. Remote examinations solve the geographic boundaries, increase the capacity of ECPs, and deliver that much sought-after convenience to patients.
Eyoto was founded as Aston Eyetech Ltd in 2013, a spinout from Aston University. It has raised over £5m in several funding rounds, most recently closing a £2.5m round led by Midven in January 2021.
CEO: Carl Francis
CTO: Jonathan Dean
Contact: https://www.eyoto.com
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
In oculis quidem se esse vult, summumque malum et, quantum.
